P. Schulze-Westhoff

674 total citations
15 papers, 534 citations indexed

About

P. Schulze-Westhoff is a scholar working on Public Health, Environmental and Occupational Health, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, P. Schulze-Westhoff has authored 15 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Public Health, Environmental and Occupational Health, 5 papers in Pharmacology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in P. Schulze-Westhoff's work include Acute Lymphoblastic Leukemia research (7 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Chemotherapy-induced cardiotoxicity and mitigation (4 papers). P. Schulze-Westhoff is often cited by papers focused on Acute Lymphoblastic Leukemia research (7 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Chemotherapy-induced cardiotoxicity and mitigation (4 papers). P. Schulze-Westhoff collaborates with scholars based in Germany, Netherlands and Latvia. P. Schulze-Westhoff's co-authors include Joachim Boos, E. Ahlke, G. Werber, Gudrun Würthwein, J. Ritter, Ulrike Nowak‐Göttl, Georg Hempel, H. Jürgens, E. J. Verspohl and Silke Flege and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and British Journal of Haematology.

In The Last Decade

P. Schulze-Westhoff

15 papers receiving 523 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Schulze-Westhoff Germany 11 322 225 143 85 77 15 534
Veerle Mondelaers Belgium 11 196 0.6× 186 0.8× 106 0.7× 25 0.3× 44 0.6× 19 415
H. Seidel Germany 14 161 0.5× 112 0.5× 42 0.3× 109 1.3× 31 0.4× 45 499
Thomas R. Cochran United States 7 88 0.3× 251 1.1× 101 0.7× 17 0.2× 144 1.9× 9 738
Ethan den Boer Netherlands 11 222 0.7× 59 0.3× 48 0.3× 155 1.8× 40 0.5× 16 425
Maciej Niedźwiecki Poland 11 81 0.3× 39 0.2× 76 0.5× 103 1.2× 59 0.8× 31 352
Takayoshi Okada Japan 14 117 0.4× 34 0.2× 50 0.3× 22 0.3× 53 0.7× 32 545
Guanghua Zhu China 11 29 0.1× 42 0.2× 59 0.4× 89 1.0× 52 0.7× 37 326
Jan A. Lieverst Netherlands 11 72 0.2× 122 0.5× 114 0.8× 38 0.4× 177 2.3× 12 448
Elżbieta Adamkiewicz-Drożyńska Poland 13 39 0.1× 76 0.3× 149 1.0× 38 0.4× 76 1.0× 46 481
Ch. Urban Austria 12 59 0.2× 48 0.2× 51 0.4× 137 1.6× 63 0.8× 38 386

Countries citing papers authored by P. Schulze-Westhoff

Since Specialization
Citations

This map shows the geographic impact of P. Schulze-Westhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Schulze-Westhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Schulze-Westhoff more than expected).

Fields of papers citing papers by P. Schulze-Westhoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Schulze-Westhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Schulze-Westhoff. The network helps show where P. Schulze-Westhoff may publish in the future.

Co-authorship network of co-authors of P. Schulze-Westhoff

This figure shows the co-authorship network connecting the top 25 collaborators of P. Schulze-Westhoff. A scholar is included among the top collaborators of P. Schulze-Westhoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Schulze-Westhoff. P. Schulze-Westhoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Koling, Susanne, et al.. (2005). Pharmacokinetics of intravenous paracetamol in children and adolescents under major surgery. European Journal of Clinical Pharmacology. 60(12). 883–888. 20 indexed citations
2.
Hempel, Georg, P. Schulze-Westhoff, Silke Flege, & Joachim Boos. (2001). Quantification of daunorubicin and daunorubicinol in plasma by capillary electrophoresis. Journal of Chromatography B Biomedical Sciences and Applications. 758(2). 221–228. 13 indexed citations
3.
Dübbers, Angelika, Gudrun Würthwein, H.-J. Müller, et al.. (2000). Asparagine synthetase activity in paediatric acute leukaemias: AML‐M5 subtype shows lowest activity. British Journal of Haematology. 109(2). 427–429. 41 indexed citations
4.
Hempel, Georg, et al.. (2000). The stability of doxorubicin and ldarubicin in plasma and whole blood. Chromatographia. 52(1-2). 9–13. 10 indexed citations
5.
Würthwein, Gudrun, et al.. (1999). Population pharmacokinetic approach to compare oral and i.v. administration of etoposide. Anti-Cancer Drugs. 10(9). 807–814. 16 indexed citations
6.
Tillmann, Barbara, Gudrun Würthwein, Alexandra L. Wagner, et al.. (1998). Pharmakokinetische Aspekte der oralen Applikation von Etoposid. Klinische Pädiatrie. 210(4). 159–164. 7 indexed citations
7.
Hempel, Georg, et al.. (1998). Therapeutic drug monitoring of doxorubicin in paediatric oncology using capillary electrophoresis. Electrophoresis. 19(16-17). 2939–2943. 44 indexed citations
8.
Hempel, Georg, et al.. (1997). Determination of idarubicin and idarubicinol in plasma by capillary electrophoresis. Journal of Chromatography B Biomedical Sciences and Applications. 698(1-2). 287–292. 38 indexed citations
9.
10.
Schiller, Meinhard, P. Schulze-Westhoff, Martin Zimmermann, et al.. (1996). Intrazelluläre Retention von Cytarabin-Triphosphat (Ara-CTP) in Blasten von Kindern mit akuter lymphoblastischer Leukämie. Klinische Pädiatrie. 208(4). 151–159. 6 indexed citations
11.
Nowak‐Göttl, Ulrike, E. Ahlke, P. Schulze-Westhoff, & Joachim Boos. (1996). Changes in coagulation and fibrinolysis in childhood ALL: a two‐step dose reduction of one E. coli asparaginase preparation. British Journal of Haematology. 95(1). 123–126. 26 indexed citations
12.
Boos, Joachim, P. Schulze-Westhoff, Meinhard Schiller, et al.. (1996). Intracellular retention of cytosine arabinoside triphosphate in blast cells from children with acute myelogenous and lymphoblastic leukemia. Medical and Pediatric Oncology. 26(6). 397–404. 18 indexed citations
13.
Boos, Joachim, G. Werber, E. Ahlke, et al.. (1996). Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations. European Journal of Cancer. 32(9). 1544–1550. 172 indexed citations
14.
Boos, Joachim, et al.. (1995). Steady-state levels and bone marrow toxicity of etoposide in children and infants: does etoposide require age-dependent dose calculation?. Journal of Clinical Oncology. 13(12). 2954–2960. 26 indexed citations
15.
Boos, Joachim, et al.. (1993). Pharmakokinetik der Etoposid-Kurzinfusionen im Rahmen der GPOH-Therapieprotokolle. Klinische Pädiatrie. 205(4). 288–294. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026